I too have been confused by their stated mill production...

First 6 Last

Share
Profile

Follow
cncventure

812 Posts.

1

10/05/16

11:58

Post #: 17722684
Share

Originally posted by loki01 ↑

I sold on the open this morning so that I could spend more time thinking about the value of the shares without having any pressure on my back to make a decision. The impression I got from the presentation is that MML will remain a very slow mover (subject to gold price variations) and there are likely to be other opportunities out there if the goldies do take a breather over the next 2-3 months.

I thought I was investing in a miner heading towards 150-170k ounce pa from FY2017 once the service shaft was installed, but now it seems that there will be no growth. The claim that the mill is operating at near 80% capacity seems misleading if one assumes that the 2500 tpd rated capacity translates to an annulised throughput of 900k tonnes and they processed only 135,725 tonnes in the March quarter which on an annualised basis comes to 60.3% of installed capacity. This implies to me that either the statement about their operating level is wrong or the mill's actual operating capacity is below its rated 2500 tpd, at perhaps only around 2000 tpd.

A key factor to the success of the company will be the grade of ore processed - which could turn out to be extremely variable, depending on the level in the mine from where the ore originated.

Good luck all.

loki (I dunno - I just do not get it, and probably never did)

Expand

I too have been confused by their stated mill production capacity versus there utilization rate.

Sorry to hear you've exited though - hope you keep an eye on MML.

That said, their seems to be HUGE volumes being traded in that $0.645 to $0.665 range. Already nearly 3 million shares have been traded this morning... not sure what's got the market so active...

It's on track to being the biggest volume traded this year (with the exception of the ASX300 rebalance)

Last edited by cncventure: 10/05/16

MML Price at posting: 67.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 16 more messages in this thread...

First 6 Last

Add MML (ASX) to my watchlist

I too have been confused by their stated mill production...

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game